| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |